Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Charles D. Gottleb
Introduction
Charles D. Gottleb is a notable inventor based in Wynnewood, Pennsylvania. He has made significant contributions to the field of medical technology, particularly in the area of cardiac health. His innovative approach to identifying infarcted myocardial tissue has the potential to improve patient outcomes in cardiology.
Latest Patents
Gottleb holds a patent for a method of using endocardial impedance to determine electrode-tissue contact. This method involves inserting an impedance measuring tip of a catheter into the chambers of a beating heart, specifically the left or right ventricle. By measuring the impedance of the endocardium at various locations, the method allows for the identification of infarcted areas of myocardium. The values obtained are compared to predetermined ranges to distinguish between normal and infarcted tissue. Additionally, the method can locate the infarction border zone, which is crucial for managing arrhythmias, particularly ventricular tachycardia. The technique also assesses the adequacy of electrode-tissue contact and evaluates the effectiveness of tissue ablation by measuring changes in impedance.
Career Highlights
Throughout his career, Charles D. Gottleb has worked with esteemed institutions such as the Philadelphia Heart Institute and the University of Pennsylvania. His work has been instrumental in advancing cardiac care and improving the safety and efficacy of procedures involving the heart.
Collaborations
Gottleb has collaborated with notable professionals in the field, including Francis E. Marchlinski and David S. Schwartzman. These collaborations have further enriched his research and contributed to the development of innovative medical technologies.
Conclusion
Charles D. Gottleb's contributions to the field of cardiology through his patented methods demonstrate his commitment to improving patient care. His innovative techniques for identifying myocardial infarction and managing arrhythmias highlight the importance of advancements in medical technology.